Ventyx Biosciences, Inc.
VTYXDelisted Mar 4, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001851194
Ventyx Biosciences, Inc. was delisted on Mar 4, 2026; its insiders filed their last Form 4 on Mar 4, 2026; 139 institutions reported holding it in 13F filings for Q4 2025, worth $471.6M in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Ventyx Biosciences, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 117
- −8 vs. Q1 2024
- Shares held
- 57.3M
- −1.75M (−3.0%) vs. Q1 2024
- Total value
- $132.3M
- −$191.6M (−59.2%) vs. Q1 2024
- New holders
- 21
- 37 more added
- Sold out
- 29
- 37 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTYX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $21.0K |
| Q4 2025 | 139 | $471.6M |
| Q3 2025 | 110 | $136.4M |
| Q2 2025 | 114 | $95.1M |
| Q1 2025 | 116 | $51.1M |
| Q4 2024 | 124 | $119.2M |
| Q3 2024 | 118 | $114.4M |
| Q2 2024 | 117 | $132.3M |
| Q1 2024 | 126 | $323.8M |
| Q4 2023 | 121 | $106.8M |
| Q3 2023 | 138 | $1.90B |
| Q2 2023 | 150 | $1.73B |
| Q1 2023 | 146 | $1.67B |
| Q4 2022 | 125 | $1.40B |
| Q3 2022 | 104 | $1.37B |
| Q2 2022 | 63 | $423.5M |
| Q1 2022 | 55 | $448.4M |
| Q4 2021 | 46 | $619.3M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Ventyx Biosciences, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sphera Funds Management Ltd. | 1,012,749 | $2.34M | 0.38% | +20,000+2.0% | Added |
| Schonfeld Strategic Advisors LLC | 1,153,941 | $2.67M | 0.02% | −1,213,059−51.2% | Reduced |
| Parkman Healthcare Partners LLC | 1,160,022 | $2.68M | 0.36% | −48,077−4.0% | Reduced |
| State Street Corp | 1,177,867 | $2.72M | 0.00% | +251,278+27.1% | Added |
| Opaleye Management Inc. | 1,190,000 | $2.75M | 0.63% | −95,000−7.4% | Reduced |
| Geode Capital Management, LLC | 1,314,352 | $3.04M | 0.00% | +207,542+18.8% | Added |
| Vestal Point Capital, LP | 1,315,000 | $3.04M | 0.23% | +1,315,000 | New |
| Goldman Sachs Group Inc | 1,459,131 | $3.37M | 0.00% | −224,957−13.4% | Reduced |
| Redmile Group, LLC | 2,164,126 | $5.00M | 0.30% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 2,391,114 | $5.52M | 0.91% | +890,000+59.3% | Added |
| Vanguard Group Inc | 2,994,242 | $6.92M | 0.00% | −711,230−19.2% | Reduced |
| Tang Capital Management LLC | 3,100,000 | $7.16M | 0.73% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 3,170,000 | $7.32M | 0.04% | 00.0% | Unchanged |
| BlackRock Inc. | 4,771,657 | $11.0M | 0.00% | +1,024,564+27.3% | Added |
| Capital International Investors | 5,247,646 | $12.1M | 0.00% | +2,893,497+122.9% | Added |
| Citadel Advisors LLC | 5,758,394 | $13.3M | 0.01% | −132,498−2.2% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 5,829,570 | $13.5M | 0.22% | +2,287,570+64.6% | Added |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −2,710,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −2,531,002−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −1,870,456−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −1,265,050−100.0% | Sold out |
| First Light Asset Management, LLC | 0 | $0 | 0.00% | −624,842−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −169,498−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −163,922−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −134,000−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −120,700−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −120,502−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −62,262−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −60,850−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −44,911−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −37,547−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −33,490−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −23,064−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −22,253−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −17,553−100.0% | Sold out |
| Zacks Investment Management | 0 | $0 | 0.00% | −16,304−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −13,180−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −11,480−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −5,177−100.0% | Sold out |
| Brown Brothers Harriman & Co | 0 | $0 | 0.00% | −2,845−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,579−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −63−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Cutler Group LP | – | – | – | – | Not filed |